Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Pfizer
Roswell Park Cancer Institute
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Pfizer
NRG Oncology
Sun Yat-sen University